gemcitabine has been researched along with DDD MPGNII in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boadle, R; Hills, K; Mahajan, H; Nankivell, B; P'ng, CH; Yong, JL | 1 |
Pazos Arias, B; Peteiro Cancelo, A; Romero Reinoso, C; Samprón Rodríguez, M; Vello Román, A | 1 |
Fracasso, PM; Grieff, M; Liapis, H; Rowinsky, EK; Stephenson, J; Tan, BR; Umbeck, NL; Von Hoff, DD | 1 |
3 other study(ies) available for gemcitabine and DDD MPGNII
Article | Year |
---|---|
Myelinoid bodies in a patient with membranoproliferative glomerulonephritis.
Topics: Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Deoxycytidine; Gemcitabine; Glomerulonephritis, Membranoproliferative; Humans; Inclusion Bodies; Kidney Glomerulus; Male; Microscopy, Electron, Transmission; Middle Aged | 2010 |
[Nephropathy following administration of angiogenesis inhibitors].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bowman Capsule; Dacarbazine; Deoxycytidine; Disease Progression; Docetaxel; Doxorubicin; Endothelium, Vascular; Fibrosarcoma; Gemcitabine; Glomerulonephritis, Membranoproliferative; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Muscle Neoplasms; Podocytes; Proteinuria; Taxoids; Vascular Endothelial Growth Factor A | 2011 |
Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bronchopneumonia; Deoxycytidine; Fatal Outcome; Gemcitabine; Glomerulonephritis, Membranoproliferative; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Vinblastine; Vinorelbine | 1999 |